Dlouhá D, Hubáček J A
Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Physiol Res. 2017 Apr 5;66(Suppl 1):S21-S38. doi: 10.33549/physiolres.933588.
MicroRNAs (miRNAs) are a class of short non-coding regulatory RNA molecules which play an important role in intracellular communication and cell signaling and which influence cellular processes such as proliferation, differentiation, and cellular death. Over the past two decades, the crucial role of microRNAs in controlling tissue homeostasis and disease in cardiovascular systems has become widely recognized. By controlling the expression levels of their targets, several miRNAs have been shown to modulate the function of endothelial cells (miR-221/222 and -126), vascular smooth muscle cells (miR-143/145) and macrophages (miR-33, -758, and -26), thereby regulating the development and progression of atherosclerosis. The stability of miRNAs within the blood suggests that circulating miRNAs may function as important biomarkers of disease development and progression. Numerous circulating miRNAs have been found to be dysregulated in a wide variety of different disease states, including diabetes, cancer, and cardiovascular disease.
微小RNA(miRNA)是一类短链非编码调节RNA分子,在细胞内通讯和细胞信号传导中发挥重要作用,并影响细胞增殖、分化和细胞死亡等细胞过程。在过去二十年中,微小RNA在控制心血管系统组织稳态和疾病方面的关键作用已得到广泛认可。通过控制其靶标的表达水平,已证明几种微小RNA可调节内皮细胞(miR-221/222和-126)、血管平滑肌细胞(miR-143/145)和巨噬细胞(miR-33、-758和-26)的功能,从而调节动脉粥样硬化的发生和发展。血液中微小RNA的稳定性表明,循环微小RNA可能作为疾病发生和发展的重要生物标志物。已发现许多循环微小RNA在包括糖尿病、癌症和心血管疾病在内的多种不同疾病状态下表达失调。